Dr Sharbhanu Ghosh Dastidar, Customer Relations, KOL, J Mitra & Co Pvt Ltd
Dr Sharbhanu Ghosh Dastidar, Customer Relations, KOL, J Mitra & Co Pvt Ltd presented industry perspective at recently held Elets Healthcare Transformation Summit. “The very first part of the diagnostic protocol of covid-19 where the challenges start is asymptomatic infection. This is due to camouflaging of the symptoms in the respiratory system.
It is very difficult for clinicians to diagnose between normal infection and covid-19. Others are mild infection followed by moderate infection, severe infection and critical infection.”
“ELISA is a simple and cheap laboratory technique. Results are typically produced within 1 to 3 hours. It can be useful for contract tracing and linking clusters of cases. J Mitra & Co.Pvt Ltd. Started its journey in 1969 to preserve human lives by promoting healthcare through technology and innovations. It’s the pioneer in manufacturing and marketing of IVD test kits in India. It’s the first Indian company to get drug manufacturing license for critical tests like HIV and HPV,” he said.
post_id:Dr. Sharbhanu Ghosh Dastidar, Customer Relations, KOL, @jmitraworld1
Due to the camouflaging of the symptoms is has been very difficult to diagnose. For the first time the molecular test has taken the centre stage during Covid19. #EletsHTS #EletsHealth pic.twitter.com/bllwIyIAx3
— eHEALTH Magazine (@ehealthonline) October 31, 2020
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
